Thinking about "drug development for childhood cancer" Symposium in Tokyo January 8, 18:28
k10012239091_202001081821_202001081834.mp4
A symposium was held in Tokyo to consider the development of drugs for childhood cancer that is less common than cancers in adults, and doctors involved in treatment appealed that new drugs should be developed simultaneously with adults and children, and that more drugs could be used. .
Childhood cancer affects more than 2,000 people annually and is the most frequent disease of death of children.However, there are more than 100 types and the number of patients is small. Has become.
At the National Cancer Center in Chuo-ku, Tokyo, a symposium on the development of drugs for childhood cancer was held, and about 100 people, including physicians, officials from pharmaceutical companies, and families of patients, participated.
Among them, Miyuki Urajiri, a representative of the patient group for neuroblastoma, said that some children died because they could not use drugs, and some children imported and used unapproved drugs. He said, "I want you to improve the situation as soon as possible."
In addition, Dr. Chitose Ogawa of the National Cancer Center Hospital said that in the case of childhood cancer, there are few drugs that can be used even if the results are known in `` cancer genomic medicine '' by examining the gene and selecting the best treatment. He said that the development of new drugs should be pursued at the same time for adults and children.
In addition, it was introduced that there is a law in the United States that promotes the development of medicines for children, and that in Japan it was necessary to improve the development environment.
Dr. Ogawa says, "It is an important step to bring drugs to children by gathering and discussing stakeholders."